Wheeler TM - Search Results

1

15S-Hydroxyeicosatetraenoic acid activates peroxisome proliferator-activated receptor gamma and inhibits proliferation in PC3 prostate carcinoma cells.

Shappell SB, Gupta RA, Manning S, Whitehead R, Boeglin WE, Schneider C, Case T, Price J, Jack GS, Wheeler TM, Matusik RJ, Brash AR, Dubois RN. Shappell SB, et al. Among authors: wheeler tm. Cancer Res. 2001 Jan 15;61(2):497-503. Cancer Res. 2001. PMID: 11212240

2

Alterations in lipoxygenase and cyclooxygenase-2 catalytic activity and mRNA expression in prostate carcinoma.

Shappell SB, Manning S, Boeglin WE, Guan YF, Roberts RL, Davis L, Olson SJ, Jack GS, Coffey CS, Wheeler TM, Breyer MD, Brash AR. Shappell SB, et al. Among authors: wheeler tm. Neoplasia. 2001 Jul-Aug;3(4):287-303. doi: 10.1038/sj.neo.7900166. Neoplasia. 2001. PMID: 11571629 Free PMC article.

3

Reduced lysyl oxidase messenger RNA levels in experimental and human prostate cancer.

Ren C, Yang G, Timme TL, Wheeler TM, Thompson TC. Ren C, et al. Among authors: wheeler tm. Cancer Res. 1998 Mar 15;58(6):1285-90. Cancer Res. 1998. PMID: 9515817

4

Growth and survival mechanisms associated with perineural invasion in prostate cancer.

Ayala GE, Dai H, Ittmann M, Li R, Powell M, Frolov A, Wheeler TM, Thompson TC, Rowley D. Ayala GE, et al. Among authors: wheeler tm. Cancer Res. 2004 Sep 1;64(17):6082-90. doi: 10.1158/0008-5472.CAN-04-0838. Cancer Res. 2004. PMID: 15342391

5

Reduced infiltration of class A scavenger receptor positive antigen-presenting cells is associated with prostate cancer progression.

Yang G, Addai J, Tian WH, Frolov A, Wheeler TM, Thompson TC. Yang G, et al. Among authors: wheeler tm. Cancer Res. 2004 Mar 15;64(6):2076-82. doi: 10.1158/0008-5472.can-03-4072. Cancer Res. 2004. PMID: 15026346

6

Combined c-Myc and caveolin-1 expression in human prostate carcinoma predicts prostate carcinoma progression.

Yang G, Timme TL, Frolov A, Wheeler TM, Thompson TC. Yang G, et al. Among authors: wheeler tm. Cancer. 2005 Mar 15;103(6):1186-94. doi: 10.1002/cncr.20905. Cancer. 2005. PMID: 15712208 Free article.

7

Primary human prostate cancer cells harboring p53 mutations are clonally expanded in metastases.

Stapleton AM, Timme TL, Gousse AE, Li QF, Tobon AA, Kattan MW, Slawin KM, Wheeler TM, Scardino PT, Thompson TC. Stapleton AM, et al. Among authors: wheeler tm. Clin Cancer Res. 1997 Aug;3(8):1389-97. Clin Cancer Res. 1997. PMID: 9815823

8

Development of an immunoassay for serum caveolin-1: a novel biomarker for prostate cancer.

Tahir SA, Ren C, Timme TL, Gdor Y, Hoogeveen R, Morrisett JD, Frolov A, Ayala G, Wheeler TM, Thompson TC. Tahir SA, et al. Among authors: wheeler tm. Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3653-9. Clin Cancer Res. 2003. PMID: 14506154

9

Clustered p53 immunostaining: a novel pattern associated with prostate cancer progression.

Yang G, Stapleton AM, Wheeler TM, Truong LD, Timme TL, Scardino PT, Thompson TC. Yang G, et al. Among authors: wheeler tm. Clin Cancer Res. 1996 Feb;2(2):399-401. Clin Cancer Res. 1996. PMID: 9816183

10

Reduced levels of transforming growth factor beta receptor type II in human prostate cancer: an immunohistochemical study.

Williams RH, Stapleton AM, Yang G, Truong LD, Rogers E, Timme TL, Wheeler TM, Scardino PT, Thompson TC. Williams RH, et al. Among authors: wheeler tm. Clin Cancer Res. 1996 Apr;2(4):635-40. Clin Cancer Res. 1996. PMID: 9816213

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

300 results

Search Page

Filters